{"id":"https://openalex.org/W2014445774","doi":"https://doi.org/10.1080/10810730.2014.934934","title":"The Association of Health Literacy With Time in Therapeutic Range for Patients on Warfarin Therapy","display_name":"The Association of Health Literacy With Time in Therapeutic Range for Patients on Warfarin Therapy","publication_year":2014,"publication_date":"2014-10-14","ids":{"openalex":"https://openalex.org/W2014445774","doi":"https://doi.org/10.1080/10810730.2014.934934","mag":"2014445774","pmid":"https://pubmed.ncbi.nlm.nih.gov/25315581"},"language":"en","primary_location":{"id":"doi:10.1080/10810730.2014.934934","doi":"https://doi.org/10.1080/10810730.2014.934934","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10810730.2014.934934","pdf_url":null,"source":{"id":"https://openalex.org/S27931387","display_name":"Journal of Health Communication","issn_l":"1081-0730","issn":["1081-0730","1087-0415"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Communication","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060189000","display_name":"Christine U. Oramasionwu","orcid":"https://orcid.org/0000-0001-9778-0979","observed_orcids":["https://orcid.org/0000-0001-9778-0979"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine U. Oramasionwu","raw_affiliation_strings":["a Division of Pharmaceutical Outcomes and Policy , University of North Carolina , Chapel Hill , North Carolina , USA","Division of Pharmaceutical Outcomes and Policy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Division of Pharmaceutical Outcomes and Policy , University of North Carolina , Chapel Hill , North Carolina , USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Division of Pharmaceutical Outcomes and Policy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012197395","display_name":"Stacy Cooper Bailey","orcid":"https://orcid.org/0000-0002-2566-3789","observed_orcids":["https://orcid.org/0000-0002-2566-3789"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacy Cooper Bailey","raw_affiliation_strings":["Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, North Carolina, USA ; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA","Division of Pharmaceutical Outcomes and Policy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, North Carolina, USA ; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Division of Pharmaceutical Outcomes and Policy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007298850","display_name":"Kristin E. Duffey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1304161147","display_name":"Mission Health","ror":"https://ror.org/02g802m02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304161147"]},{"id":"https://openalex.org/I4210148509","display_name":"Mission Hospital","ror":"https://ror.org/04vcxwm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130773","https://openalex.org/I4210148509"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin E. Duffey","raw_affiliation_strings":["Mission Hospital Outpatient Clinical Pharmacy Services, Asheville, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mission Hospital Outpatient Clinical Pharmacy Services, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I1304161147","https://openalex.org/I4210148509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027228130","display_name":"Betsy Bryant Shilliday","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betsy Bryant Shilliday","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA ; UNC Health Care, and the School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA","UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","UNC Health Care, and the School of Medicine , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA ; UNC Health Care, and the School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]},{"raw_affiliation_string":"UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"UNC Health Care, and the School of Medicine , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048712328","display_name":"Lori C. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1304161147","display_name":"Mission Health","ror":"https://ror.org/02g802m02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304161147"]},{"id":"https://openalex.org/I4210148509","display_name":"Mission Hospital","ror":"https://ror.org/04vcxwm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130773","https://openalex.org/I4210148509"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori C. Brown","raw_affiliation_strings":["Mission Hospital Outpatient Clinical Pharmacy Services, Asheville, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mission Hospital Outpatient Clinical Pharmacy Services, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I1304161147","https://openalex.org/I4210148509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084723369","display_name":"Sheri A. Denslow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1304161147","display_name":"Mission Health","ror":"https://ror.org/02g802m02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304161147"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheri A. Denslow","raw_affiliation_strings":["Mission Hospital Research Institute, Asheville, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mission Hospital Research Institute, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I1304161147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010446274","display_name":"Elizabeth Landrum Michalets","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1304161147","display_name":"Mission Health","ror":"https://ror.org/02g802m02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304161147"]},{"id":"https://openalex.org/I4210148509","display_name":"Mission Hospital","ror":"https://ror.org/04vcxwm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130773","https://openalex.org/I4210148509"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Landrum Michalets","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA ; Mission Hospital Department of Pharmacy, Asheville, North Carolina, USA","Mission Hospital Department of Pharmacy ,  Asheville ,  North Carolina ,  USA","UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA ; Mission Hospital Department of Pharmacy, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1304161147"]},{"raw_affiliation_string":"Mission Hospital Department of Pharmacy ,  Asheville ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I1304161147","https://openalex.org/I4210148509"]},{"raw_affiliation_string":"UNC Eshelman School of Pharmacy , University of North Carolina ,  Chapel Hill ,  North Carolina ,  USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5060189000"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":6.2439,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.95735249,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"19","issue":"sup2","first_page":"19","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10737","display_name":"Health Literacy and Information Accessibility","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10737","display_name":"Health Literacy and Information Accessibility","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/health-literacy","display_name":"health literacy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.972000002861023},{"id":"https://openalex.org/keywords/anticoagulation-management","display_name":"anticoagulation management","score":0.9269999861717224},{"id":"https://openalex.org/keywords/time-in-therapeutic-range","display_name":"time in therapeutic range","score":0.9710000157356262},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7009999752044678},{"id":"https://openalex.org/keywords/medication-knowledge","display_name":"medication knowledge","score":0.6200000047683716},{"id":"https://openalex.org/keywords/narrow-therapeutic-index-drugs","display_name":"narrow therapeutic index drugs","score":0.8299999833106995},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.8550000190734863},{"id":"https://openalex.org/keywords/anticoagulation-clinic","display_name":"anticoagulation clinic","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.9209784865379333},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8926525712013245},{"id":"https://openalex.org/C2778843546","wikidata":"https://www.wikidata.org/wiki/Q3097973","display_name":"Health literacy","level":3,"score":0.8917485475540161},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5887637138366699},{"id":"https://openalex.org/C547764534","wikidata":"https://www.wikidata.org/wiki/Q8236","display_name":"Literacy","level":2,"score":0.5108453631401062},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4097242057323456},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3779701888561249},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34336432814598083},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23972651362419128},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.15844547748565674},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.10464975237846375},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.06861576437950134},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C19417346","wikidata":"https://www.wikidata.org/wiki/Q7922","display_name":"Pedagogy","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007722","descriptor_name":"Health Knowledge, Attitudes, Practice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057220","descriptor_name":"Health Literacy","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10810730.2014.934934","doi":"https://doi.org/10.1080/10810730.2014.934934","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10810730.2014.934934","pdf_url":null,"source":{"id":"https://openalex.org/S27931387","display_name":"Journal of Health Communication","issn_l":"1081-0730","issn":["1081-0730","1087-0415"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Communication","raw_type":"journal-article"},{"id":"pmid:25315581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25315581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of health communication","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G3969538665","display_name":"North Carolina Translational & Clinical Sciences Institute (NC TraCS)","funder_award_id":"UL1TR001111","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W656268522","https://openalex.org/W1585955360","https://openalex.org/W1586488555","https://openalex.org/W1871158536","https://openalex.org/W1972916440","https://openalex.org/W1976091401","https://openalex.org/W1980153874","https://openalex.org/W1987338200","https://openalex.org/W1990217769","https://openalex.org/W1994558104","https://openalex.org/W1995044128","https://openalex.org/W1996588372","https://openalex.org/W1998210599","https://openalex.org/W2005235226","https://openalex.org/W2012923240","https://openalex.org/W2016915066","https://openalex.org/W2022396772","https://openalex.org/W2028568079","https://openalex.org/W2030703473","https://openalex.org/W2047727756","https://openalex.org/W2061451084","https://openalex.org/W2068254531","https://openalex.org/W2085714022","https://openalex.org/W2103053426","https://openalex.org/W2106143461","https://openalex.org/W2111192628","https://openalex.org/W2114431606","https://openalex.org/W2136947748","https://openalex.org/W2141435397","https://openalex.org/W2151946837","https://openalex.org/W2157822705","https://openalex.org/W2162508946","https://openalex.org/W2328538662","https://openalex.org/W2887568033"],"related_works":["https://openalex.org/W1980153874","https://openalex.org/W2592870145","https://openalex.org/W1967773573","https://openalex.org/W2085714022","https://openalex.org/W2794274730","https://openalex.org/W2090074334","https://openalex.org/W4390240022","https://openalex.org/W2068254531","https://openalex.org/W2139469338","https://openalex.org/W4233531213"],"abstract_inverted_index":{"Patients":[0],"on":[1,60,173],"warfarin":[2,36,62,81,174],"therapy":[3,82],"need":[4],"to":[5,13,31,35,48,138],"achieve":[6],"and":[7,33,40,55,123,184],"maintain":[8],"anticoagulation":[9,56,70,89,127,169],"control":[10,57,128,170],"in":[11,37,72,76,106],"order":[12],"experience":[14],"the":[15,50,96,100,110,182],"benefits":[16],"of":[17,88,99,102,121,177,187],"treatment":[18],"while":[19],"minimizing":[20],"bleeding":[21],"risk.":[22],"Low":[23],"health":[24,53,117,133,145,163],"literacy":[25,54,92,118,134,146,164],"skills":[26],"may":[27,180],"hinder":[28,181],"patients'":[29],"ability":[30],"use":[32,186],"adhere":[34],"a":[38,86],"safe":[39,183],"effective":[41,185],"manner.":[42],"The":[43],"authors":[44],"conducted":[45],"this":[46,188],"study":[47,112],"evaluate":[49],"relationship":[51],"between":[52],"among":[58],"patients":[59,172],"chronic":[61],"therapy.":[63,175],"Participants":[64,130],"were":[65,135],"recruited":[66],"from":[67],"2":[68],"diverse":[69],"clinics":[71],"North":[73],"Carolina.":[74],"Time":[75],"therapeutic":[77,190],"range":[78],"(TTR)":[79],"for":[80,171],"was":[83,93,147],"used":[84],"as":[85],"measure":[87],"control.":[90],"Health":[91,104],"assessed":[94],"using":[95],"short":[97],"form":[98],"Test":[101],"Functional":[103],"Literacy":[105],"Adults":[107],"(S-TOFHLA).":[108],"Of":[109],"198":[111],"participants,":[113],"51%":[114],"had":[115,125],"limited":[116,132,162],"(S-TOFHLA":[119],"score":[120],"0-90)":[122],"33%":[124],"poor":[126,168],"(TTR<50%).":[129],"with":[131,150,167],"less":[136],"likely":[137],"correctly":[139],"answer":[140],"warfarin-related":[141],"knowledge":[142],"questions.":[143],"Limited":[144],"significantly":[148],"associated":[149,166],"TTR<50%":[151],"(adjusted":[152],"odds":[153],"ratio=2.34,":[154],"95%":[155],"CI":[156],"[1.01,":[157],"5.46]).":[158],"Findings":[159],"indicate":[160],"that":[161],"is":[165],"Lack":[176],"medication":[178],"understanding":[179],"narrow":[189],"index":[191],"drug.":[192]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}